期刊文献+

锯叶棕提取物治疗BPH伴OAB的疗效观察 被引量:2

Effect study of saw palmetto extract in the treatment of benign prostatic hyperplasia with overactive bladder
原文传递
导出
摘要 目的:探讨锯叶棕提取物治疗BPH伴膀胱过度活动症(OAB)的临床疗效。方法:将2012年7月~2013年3月在我院诊断为BPH伴OAB患者100例随机分为研究组50例及对照组50例,研究组口服锯叶棕提取物(沙芭特)160mg,每天2次;对照组口服坦索罗辛0.2mg,每天1次。两组患者均服药8周,对比观察两组开始服药前、服药8周后的IPSS评分、OABSS评分、生活质量评分、最大尿流率(Qmax)、24h排尿次数、夜尿次数、每次排尿量等指标,观察研究组用药前后的疗效。结果:两组患者OAB较治疗前均有明显好转,治疗前后各项指标差异具有统计学意义(P〈0.05);除max外,研究组与对照组其余观察指标治疗前后的变化值比较,差异均有统计学意义(P〈0.05)。结论:锯叶棕提取物(沙芭特)对于BPH伴OAB有明显的治疗作用,临床疗效较好。 Objective:To evaluate the clinical efficacy of saw palmetto extract in the treatment of benign prostatic hyperplasia patients with overactive bladder. Methods: 100 case were included and were randomly divided into the trial group (50 cases) and control group(50 cases). Patients in trial group were adminstrated with saw palmet- to extract at 160 mg and in control group were with tamsulosin at 0.2rag once daily for 8 weeks. The efficacy of treatment were assessed by changes before and after treatment in IPSS, OABSS, Quality of life score, Qmax, ally frequency of micturition, the number of nocturia, voiding volumes. Results: There are significant differences in out- come in trial group between before and after treatment(P〈0.05). There are no significant difference in the chan- ges before and after treatment betweem two groups. There are significant differences in changes before and after treatment of subjective and objective outcome measures except for Q and voiding volumes(P〈0.05). Conclusions:Combination saw palmetto extract in treatment of benign prostatic hyperplasia patients with OAB has efficacy.
作者 白立刚
出处 《临床泌尿外科杂志》 2013年第6期443-445,共3页 Journal of Clinical Urology
关键词 良性前列腺增生 膀胱过度活动后症 锯叶棕提取物 benign prostatic hyperplasia overactive bladder saw palmetto extract
  • 相关文献

参考文献4

二级参考文献76

  • 1吕坚伟,周立新,冷静,黄翼然,唐涌志,汤海,闵志廉,高轶.萘哌地尔与盐酸特拉唑嗪治疗良性前列腺增生的疗效与安全性评估[J].中国男科学杂志,2005,19(5):36-39. 被引量:20
  • 2YANG Yong,ZHAO Xiao-feng,LI Han-zhong,WANG Wei,ZHANG Yong,XIAO He,ZHANG Xin.Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a prospective study[J].Chinese Medical Journal,2007(5):370-374. 被引量:12
  • 3Roehrborn CG, Rosen RC. Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfusozin 10 mg once daily. Chn Interv Aging 2008; 3: 511-24.
  • 4Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G, et al. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. N Engl J Med 1996; 335: 533-9.
  • 5Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St John's Wort, Ginseng, Echinacea, Saw palmetto, and Kava. Ann Intern Med 2002; 136: 42-53.
  • 6Wilt TJ, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 1998; 280: 1604-9.
  • 7Lowe FC, Ku JC. Phytotherapy in treatment of benign prostatic hyperplasia: a critical review. Urology 1996; 48: 12-20.
  • 8Koch E. Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms. Planta Med 2001; 67: 489-500.
  • 9McNaughton-Collins M, Barry MJ. Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Am J Med 2005; 118: 1331-9.
  • 10Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, et al. Saw palmetto for benign prostatic hyperplasia. N Engl J Med 2006; 354: 557-66.

共引文献166

同被引文献49

  • 1姚明辉.锯叶棕提取物(SPE)的药理作用及临床应用.中国药理学会第七届全国生殖药理学术交流会论文摘要汇编[c].贵州:中国药理学会生殖药理学专业委员会,2011:6.
  • 2BONVISSUTO G, MINUTOLI L, MORGIA G, et al. Effect of Serenoa repens, lycopene, and selenium on proinflammatory phe- notype activation: an in vitro and in vivo comparison study[ J]. Urology, 2011, 77(1): 248.
  • 3ROSLER TW, MATUSCH R, WEBER B, et al. Analysis of the hydrodistillate from the fruits of Serenoa repens [ J ]. Planta Med, 2009, 75(2) : 184 -186.
  • 4U. S. USP. USP Saw Palmetto Capsules, Saw Palmetto Extract [ S]. USP35-NF30, 1435 - 1439. The United States Pharmaco-peial Convention, official from August 1, 2012.
  • 5SORENSON WR, SULLIVAN D. Determination of campesteroL, stigmasteroL, and beta-sitosterol in saw palmetto raw materials and dietary suppLements by gas chromatography: Collaborative study [ J ]. J AOAC lnt, 2007, 90 (3) : 670 - 678.
  • 6ABE M, ITO Y, OYUNZUL L, et al. Pharmacologically relevant receptor binding characteristics and 5ct-reductase inhibitory activ- ity of free fatty acids contained in saw palmetto extract [ J ]. Biol Pharm Bull, 2009, 32 (4) : 646 - 650.
  • 7ARRUZAZABALA ML, PEREZ Y, RAVELO Y, et al. Effect of oleic, lauric and myristic acids on phenylephrine-induced con- tractions of isolated rat vas deferens [ J ]. Indian J Exp Biol, 2011, 49(9) : 684 -688.
  • 8SCHANTZ MM, BEDNER M, LONG SE, et al. Development of saw palmetto (Serenoa repens) fruit and extract standard refer- ence materials [ J ]. Anal Bioanal Chem, 2008, 392 (3) : 427 - 438.
  • 9郭军,宋春生,韩强,张牧川,张彤,张强,余国今,杨阳,杜宝俊.滋阴通闭汤治疗良性前列腺增生症的临床观察[J].中国中西医结合杂志,2008,28(12):1082-1085. 被引量:13
  • 10周谊霞,黄永红,江华容,张燕,张元华,陈方敏.功能锻炼对良性前列腺增生伴逼尿肌乏力患者术后恢复的研究[J].护士进修杂志,2009,24(19):1767-1768. 被引量:2

引证文献2

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部